Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout and Moderate Renal Impairment

NCT02128490 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

189

Enrollment

INDUSTRY

Sponsor class

Conditions

Gout
Moderate Renal Impairment

Interventions

DRUG: Febuxostat IR
DRUG: Febuxostat XR
DRUG: Febuxostat placebo
DRUG: Colchicine
DRUG: Naproxen
DRUG: Lansoprazole

Sponsor

Takeda